Review Article
A Review on Treatment of Premature Ovarian Insufficiency: Characteristics, Limitations, and Challenges of Stem Cell versus ExosomeTherapy
Figure 3
CD44+/CD105+HAFMSCs-exosomes carrying miR-369-3p have the capacity to specifically downregulate the expression of YAF2, prevent the stability of PDCD5/p53, and decrease the apoptosis of GCs, leading to the restorative effect on POF.